Clinical Definition

HNS works by:

  • Nerve Stimulation: Electrical stimulation of the hypoglossal nerve
  • Tongue Activation: Causing the genioglossus muscle to contract
  • Airway Opening: Moving the tongue forward to open the airway
  • Synchronized Delivery: Timed with the patient's breathing cycle
  • Adjustable Therapy: Programmable stimulation parameters

The system detects the patient's breathing pattern and delivers stimulation during inspiration to move the tongue forward and maintain airway patency.

Etymology & History

HNS was developed based on research showing that stimulation of the hypoglossal nerve could prevent airway collapse. The first clinical studies began in the early 2000s, leading to FDA approval of the first commercial system in 2014.

Reference Values & Interpretation

Normal Values

Successful HNS typically reduces AHI by ≥50% and to <20 events per hour. Clinical studies show success rates of 60-70% in appropriately selected patients, with sustained benefits over time.

Abnormal Values

HNS complications can include surgical risks, device-related issues, temporary tongue weakness, tooth damage, or inadequate therapeutic response. Most complications are manageable with proper care.

How It's Measured

HNS outcomes are evaluated through follow-up sleep studies, typically performed 2-3 months after device activation, along with clinical assessment and device data review.

Role in Diagnosis

HNS is used for carefully selected OSA patients who meet strict criteria and have failed CPAP therapy. Comprehensive preoperative evaluation is essential to identify suitable candidates.

Role in Treatment

HNS provides an effective treatment option for appropriately selected patients with OSA. It offers good compliance rates and significant improvements in sleep quality and daytime function.

Associated Conditions

inspire-therapy|upper-airway-stimulation|hypoglossal-nerve

">

Clinical Guidelines

[{"guideline_title":"AASM Clinical Practice Guideline for Hypoglossal Nerve Stimulation","guideline_link":"/clinical/guidelines/aasm-hypoglossal-stimulation/"}]

Latest Research & Updates

AI-Updated Weekly

Ongoing research is investigating new HNS technologies, expanded patient selection criteria, and combination therapies to improve outcomes for a broader range of OSA patients.